Literature DB >> 19743770

Using biomarkers of aging to identify modifiable mechanisms underlying age-related risk for cancer.

Halcyon G Skinner1, Ronald Gangnon, Lisa A Boardman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19743770      PMCID： PMC3874855     

Source DB:  PubMed          Journal:  WMJ        ISSN： 1098-1861


× No keyword cloud information.
  20 in total

Review 1.  The age of cancer.

Authors:  R A DePinho
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

2.  Biomarkers of aging: from primitive organisms to humans.

Authors:  Robert N Butler; Richard Sprott; Huber Warner; Jeffrey Bland; Richie Feuers; Michael Forster; Howard Fillit; S Mitchell Harman; Michael Hewitt; Mark Hyman; Kathleen Johnson; Evan Kligman; Gerald McClearn; James Nelson; Arlan Richardson; William Sonntag; Richard Weindruch; Norman Wolf
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-06       Impact factor: 6.053

Review 3.  Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes.

Authors:  M J Sampson; D A Hughes
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

4.  A human telomeric protein.

Authors:  L Chong; B van Steensel; D Broccoli; H Erdjument-Bromage; J Hanish; P Tempst; T de Lange
Journal:  Science       Date:  1995-12-08       Impact factor: 47.728

5.  Comparison of the human and mouse genes encoding the telomeric protein, TRF1: chromosomal localization, expression and conserved protein domains.

Authors:  D Broccoli; L Chong; S Oelmann; A A Fernald; N Marziliano; B van Steensel; D Kipling; M M Le Beau; T de Lange
Journal:  Hum Mol Genet       Date:  1997-01       Impact factor: 6.150

6.  Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors.

Authors:  D Gisselsson; T Jonson; A Petersén; B Strömbeck; P Dal Cin; M Höglund; F Mitelman; F Mertens; N Mandahl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

7.  Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.

Authors:  V Hakin-Smith; D A Jellinek; D Levy; T Carroll; M Teo; W R Timperley; M J McKay; R R Reddel; J A Royds
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

8.  Role of the TRF2 telomeric protein in cancer and ageing.

Authors:  Purificación Muñoz; Raquel Blanco; María A Blasco
Journal:  Cell Cycle       Date:  2006-04-01       Impact factor: 4.534

9.  Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control.

Authors:  Orit Uziel; Joelle Attal Singer; Vladimir Danicek; Gideon Sahar; Evgeny Berkov; Michael Luchansky; Abigail Fraser; Ron Ram; Meir Lahav
Journal:  Exp Gerontol       Date:  2007-07-20       Impact factor: 4.032

10.  Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis.

Authors:  Alan K Meeker; Jessica L Hicks; Christine A Iacobuzio-Donahue; Elizabeth A Montgomery; William H Westra; Theresa Y Chan; Brigitte M Ronnett; Angelo M De Marzo
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531
View more
  1 in total

Review 1.  Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Authors:  Nivedita Basu; Halcyon G Skinner; Kristin Litzelman; Russell Vanderboom; Esha Baichoo; Lisa A Boardman
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11       Impact factor: 3.869
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.